Login to Your Account



Financings Roundup

Kythera, Intercept Dazzle with Dueling Initial Public Offerings

By Catherine Shaffer
Staff Writer

Thursday, October 11, 2012
financings_resized.jpg

Intercept Pharmaceuticals Inc. and Kythera Biopharmaceuticals Inc. each priced initial public offerings (IPO) at the top of their ranges Thursday, and both companies' stock surged, selling several dollars above even that top price.

Intercept (NASDAQ:ICPT) gained 30 percent, or $4.40, to close at $19.40, and Kythera (NASDAQ:KYTH) gained 23.7 percent, or $3.79, to close at $19.79.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription